Cite

HARVARD Citation

    Kumar, S. et al. (n.d.). The Effect of Rosiglitazone on Bone Mass and Fragility Is Reversible and Can Be Attenuated With Alendronate. Journal of bone and mineral research. pp. 1653-1665. [Online]. 
  
Back to record